| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a135a933620c99beab01d4ac785d25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d779448e816f508915ebf0e60c0ba809
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3929a0157118af1f1c610847ee26be57 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0071 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 |
| filingDate |
2000-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2001-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90c147efbc21ea97abe59cb87c148a02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b11a894ecc9715a6d2e9348a0c0d3995
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1acdf1f10cae70dec7dc605e2b4681a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_930d133a30a3a10265b2d5e792e274b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_623496b2479f40f443db7e6532e8bd25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b99da44a8088a1740c143cc9f5b76b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_508bd47ef10b3e29d903713bc97a38f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4838d8e779657a9f47816c1326abd274
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01c33eb097e898ccdd2607bb97702057 |
| publicationDate |
2001-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6248734-B1 |
| titleOfInvention |
Use of photodynamic therapy for prevention of secondary cataracts |
| abstract |
Photodynamic therapy to prevent secondary cataracts is effected using photosensitizers such as green porphyrins as photoactive agents to destroy remnant lens epithelial cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6838074-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6673067-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004122491-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0219594-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0219594-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2802302-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003148393-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7193706-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023096818-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004011460-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7753943-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006231107-A1 |
| priorityDate |
1996-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |